SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Repurposing Strategies for Therapeutics
1 references·7 citing·32 second hop
Repurposing Strategies for Therapeutics (2010)Repurposing Strategies for TherapeuticsLessons from 60 years of pharmaceutical innovation (2009)Lessons from 60 years of phar…Mapping Markush (2022)Mapping MarkushTowards FAIR protocols and workflows: the OpenPREDICT use case (2020)Towards FAIR protocols and wo…Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments (2020)Drug Repurposing: Considerati…How does the partner type in R&D alliances impact technological innovation performance? A study on the Korean biotechnology industry (2015)How does the partner type in …Drug repurposing and the prior art patents of competitors (2014)Drug repurposing and the prio…Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications (2014)Drug reformulations and repos…Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature (2013)Drug reformulations and repos…Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)The price of innovation: new estimates of drug development costs (2003)The black swan: the impact of the highly improbable (2007)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Patents and Innovation: An Empirical Study (1986)Patents and innovation: an empirical study (1986)Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory (2017)Repositioned drugs: integrating intellectual property and regulatory strategies (2011)Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases (2013)The value of drug repositioning in the current pharmaceutical market (2009)The value of drug repositioning in the current pharmaceutical market (2009)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Exploration and Exploitation in Organizational Learning (1991)The Commitment-Trust Theory of Relationship Marketing (1994)Bibliometric analysis of absorptive capacity (2017)An investigation over inbound open innovation in SMEs: insights from an Italian manufacturing sample (2019)Network embeddedness and innovation performance: a mediation moderation analysis using PLS-SEM (2021)Why Most Published Research Findings Are False (2005)Why Most Published Research Findings Are False (2005)1,500 scientists lift the lid on reproducibility (2016)User-friendly Composition of FAIR Workflows in a Notebook Environment (2021)Formal definition and implementation of reproducibility tenets for computational workflows (2024)Visual programming-based Geospatial Cyberinfrastructure for open-source GIS education 3.0 (2025)Drugs for neglected diseases: a failure of the market and a public health failure? (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)A Penny for Your Quotes: Patent Citations and the Value of Innovations (1990)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Market value and patent citations (2005)Divide and conquer: Relating patent quality and value in a conceptual framework based on a systematic review (2023)Death squad or quality improvement? The impact of introducing post-grant review on U.S. patent legal quality (2025)Interpretive aspects of claim language and patent scope (2025)
this work references cited by second hop

References

  • 2009Lessons from 60 years of pharmaceutical innovation1,238 cited

Cited by

  • 2013Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature65 cited
  • 2015How does the partner type in R&D alliances impact technological innovation performance? A study on the Korean biotechnology industry55 cited
  • 2014Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications55 cited
  • 2020Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments50 cited
  • 2014Drug repurposing and the prior art patents of competitors26 cited
  • 2020Towards FAIR protocols and workflows: the OpenPREDICT use case19 cited
  • 2022Mapping Markush16 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work